Introduction
Seasonal allergic rhinitis due to cedar pollens are a common problem in multiple areas in the world (Goldblum et al., 2016; Pichler et al., 2015; Midoro-Horiuti, 1992; Midoro-Horiuti et al., 1992) . For instance, about 30-40% of the populations of central US, Southern Europe and Japan, suffer from cedar pollen hypersensitivities to highly cross-reactive allergens of the mountain cedar (Juniperus ashei, Cupressaceae), Italian cypress (Cupressus sempervirens, Cupressaceae) and Japanese cedar (Cryptomeria japonica, Taxodiaceae). We have previously isolated, cloned, sequenced and elucidated the crystal or model structure and IgE epitopes of two of these allergens, Jun a 1 and Jun a 3, from mountain cedar pollen (Midoro-Horiuti et al., 1999 Soman et al., 2000; Midoro-Horiuti et al., 2003; Liu et al., 2003; Czerwinski et al., 2005; Varshney et al., 2007) . We also reported that the majority of human IgE antibodies from the sera of mountain cedar allergy sufferers are directed against several conformational epitopes on the surface of the dominant allergen, Jun a 1 (Goldblum et al., 2014) . There are reports about the analyses of IgE and IgG epitopes on the other pollen allergens. The conformational IgE epitopes are reported on Bet v 1 (Mirza et al., 2000; Gieras et al., 2011; Subbarayal et al., 2013) , Amb a 4 (Pablos et al., 2018) , Amb a 8 (Offermann et al., 2016) , Cry j 1 (Aoki et al., 2009) , Phl p 2 (Padavattan et al., 2009) , Phl p 3 (Devanaboyina et al., 2014) and Phl p 5 (Focke-Tejkl et al., 2014) . Also, conformational IgG epitopes are reported on Bet v 1 (Subbarayal et al., 2013) .
We describe here a population-based study comparing three groups of atopic subjects, all of whom were naturally exposed yearly to mountain cedar pollen, in the same region. The first group did not display allergic symptoms or skin prick test (SPT) responses to mountain cedar extracts (SPT − ). The second group had seasonal, clinical manifestations of cedar pollinosis and positive SPT, but had not been treated with specific immunotherapy (SPT + SIT + ). The third group had seasonal symptoms, was SPT + and had been treated with subcutaneous immunotherapy with mountain cedar pollen extracts (SPT + SIT + ). Our goal for this epidemiologic study was to identify the similarities and differences in the serum antibody responses to Jun a 1, in these three clinical groups.
commercial extract of mountain cedar pollen (Hollister-Stier, Spokane, WA), if they had not been tested in the previous year. Sera from the three groups of atopic adults, all of whom were seasonally exposed to mountain cedar pollen in the same region and were recruited from Dr. van Bavel's clinic at Austin, Texas. We distributed these subjects into three clinical groups. The first group did not display allergic symptoms or SPT responses to mountain cedar extract (SPT − , n = 10). The second group had seasonal clinical manifestations of cedar pollinosis and positive skin prick tests, but were not treated with specific immunotherapy (SPT + SIT − , n-12). The third group had seasonal symptoms, positive SPT and were treated with allergen specific immunotherapy (SPT + SIT + , n = 12).
Purification of Jun a 1
Jun a 1 was purified from mountain cedar pollen, as we previously described (Midoro-Horiuti et al., 1999) .
Enzyme linked immuno assay (ELISA) assays
To quantify the IgE, IgA, IgG and IgG4 serum antibodies to Jun a 1, 96 well microtiter plates were coated by incubating with native, purified Jun a 1 (3 μg/mL) at 37°C overnight (Midoro-Horiuti et al., 1999) . Then various dilutions of the sera (1:10 to 1:10 9 in 0.01% Tween 20-Tris buffered saline, TTBS) from each subject were incubated in duplicate wells for 4 h. After washing the microtiter plates, the quantity of IgE bound to the wells was detected, using biotinylated goat antihuman IgE (Vector, Burlingame, CA), followed by horseradish peroxidase (HRP)-streptavidin conjugates. The binding of IgA, IgG and IgG4 were detected by incubation with anti-human IgA, IgG or IgG4 enzyme conjugates (Zymed, San Francisco, CA). After washing the microtiter plates, the patient's immunoglobulins of each isotype, that bound to the wells was quantified using 3,3′,5,5′-Tetramethylbenzidine (TMB, Sigma). The results from the colorimetric enzyme assays were then plotted, to establish the highest dilution that had color significantly above the buffer control. The number of dilutions was considered the titer for that isotype.
ELISAs to distinguish between antibodies that bind to native and denatured Jun a 1
To determine the extent to which individual patient's IgE, IgA, IgG and IgG4 antibodies react to conformational and linear epitopes of Jun a 1, we used similar ELISA assays, which we described previously (Varshney et al., 2007; Goldblum et al., 2014) . Some of these coated wells were incubated with 6 mol/L guanidine-HCl for 30 min, to denature the Jun a 1. The sera from the members of each of the three clinical groups were then serially diluted and incubated in either the guanidine-treated and untreated wells. The binding of each isotype, to native and denatured Jun a 1, was detected and the results plotted as described above.
Results and discussion

Patient demographics
There were no significant differences in the gender or age distribution between these three groups. The mean male: female ratios were (3:7, 7:5 and 4:6), and ages ± SD were 31.9 ± 11.7, 37.9 ± 12.1 and 44.2 ± 8.9) for SPT − , SPT 
Titer of Jun a 1 specific immunoglobulins
We first assessed each subject's titers of serum IgE, IgA, IgG and IgG4 antibodies to Jun a 1, using ELISA assays, as described above ( Fig. 1) (Goldblum et al., 2014) . We could not distinguish any differences in the concentration of serum IgA anti-Jun a 1 antibodies between these three groups (Fig. 1) . However, we found a significantly higher concentration of IgG anti-Jun a 1 antibodies in the sera of the SPT + SIT − , than in the other two groups. The IgG4 anti-Jun a 1 concentrations were too low to be accurately quantified in most of the 1:10 diluted sera. The lines above the graph indicate the significant differences between the groups for IgG and IgE isotypes.
Recognition of conformational vs. linear epitopes of Jun a 1 by each antibody isotype
We next examined the types of molecular structures on Jun a 1 that were recognized by each isotype, by testing the same sera in ELISA wells, in which the conformational (discontinuous) epitopes were disrupted by pretreating Jun a 1 coated wells with guanidine ( Fig. 2 ), as we previously described. The results of these assays showed that IgE antibody are strongly directed toward conformational epitopes, while IgA and total IgG are less selective for these structures. This is indicated in the SPT + SIT − group (Fig. 2B) , by the loss (80-100%) of their IgE reactivity when assayed on the denatured Jun a 1 (mean ± SD = 95 ± 3). However, binding of their IgA, IgG and IgG4 was less affected by this denaturation (43 ± 24, 27 ± 22 and 58 ± 27%, p < 0.00005, 0.0005 and 0.06), respectively. These findings strongly suggest that pathologic IgE antibodies to Jun a 1 predominantly bind to conformational epitopes, while the IgA and total IgG antibodies recognize both SPT: skin pick test, SIT: specific immunotherapy.
R.M. Goldblum et al. Molecular Immunology 101 (2018) 527-530 linear and conformational epitopes on Jun a 1, in the SIT − groups. IgG4 antibody binding, generally favored denatured Jun a 1.
Potential mechanism of allergen specific immunoglobulin production
Together these findings suggest that IgE and most of the IgG4 antibodies to cedar allergen were directed against native Jun a 1 in the local mucosal tissues, prior to inhalation or ingestion, during which the pollen proteins would be denatured, as reported by others (Rondon et al., 2007 (Rondon et al., , 2012 Wise et al., 2009; Yoshida et al., 2005) . However, IgG and IgA antibodies, produced in response to the same exposures, are most likely produced against allergens that are transported through the nasal mucosa or swallowed, and then denatured in the gastrointestinal tract, or upon systemic absorption. None, or very few, IgE antibodies were detected in the sera from the SPT − subjects. However, these subjects did produce Jun a 1-specific IgA, IgG and IgG4
antibodies. Thus, while allergen-specific IgE antibodies from mountain cedar allergic patients recognize predominantly conformational epitopes, less than half of their IgA and IgG antibodies, like those from non-cedar Fig. 1 . Titer of Jun a 1-specific IgE, IgG and IgA antibodies are shown with their mean ± SD (open bars). IgG4 antibodies were not shown in this figure because of their very low titers. Significance differences in the titer of different isotypes are indicated by * P < 0.05, ** P < 0.005, *** P < 0.0005. Fig. 2 . Decrease in the binding of each immunoglobulin isotype after Jun a 1 was denatured with guanidine is shown as the percent decrease. *P < 0.05, **P < 0.005, ***P < 0.0005, as indicated. allergic donors, recognize conformational epitopes. This pattern of epitope recognition suggests a local (mucosal) production of allergenspecific IgE. However, after systemic immunotherapy, the proportion of allergen specific IgG, and particularly IgG4, that recognize conformational epitopes is increased. Taken together these findings may indicate that successful subcutaneous immunotherapy for cedar pollen may depend, at least in part, on the ability of IgG antibodies to recognize conformational epitopes.
Conclusion
Detailed examination of the isotype-specific patterns of human antibody responses to structurally distinct features on allergens, and their responses to therapeutic interventions, may allow us to identify new approaches to allergic diseases and/or help to predict which patient's will respond to these interventions.
